Two Sigma Securities, LLC Athersys, Inc Transaction History

Two Sigma Securities, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.6 - $1.06 $32,720 - $57,806	-54,534 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.4 $46,353 - $76,347	54,534 New	54,534 $49,000
Q2 2021 Aug 16, 2021	SELL	$1.41 - $1.94 $24,158 - $33,239	-17,134 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.61 - $2.77 $27,585 - $47,461	17,134 New	17,134 $31,000
Q1 2020 May 15, 2020	SELL	$1.17 - $3.0 $21,604 - $55,395	-18,465 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.16 - $1.42 $21,419 - $26,220	18,465 New	18,465 $23,000
Q3 2019 Nov 14, 2019	SELL	$1.21 - $1.65 $34,159 - $46,581	-28,231 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.39 - $2.03 $3,373 - $4,926	2,427 Added 9.41%	28,231 $47,000
Q1 2019 May 15, 2019	SELL	$1.39 - $1.71 $9,485 - $11,669	-6,824 Reduced 20.91%	25,804 $39,000
Q4 2018 Feb 14, 2019	BUY	$1.41 - $2.16 $46,005 - $70,476	32,628 New	32,628 $47,000
Q4 2017 Feb 14, 2018	SELL	$1.65 - $2.45 $53,521 - $79,470	-32,437 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$1.5 - $2.55 $48,655 - $82,714	32,437	32,437 $67,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.